![]() |
市场调查报告书
商品编码
1562247
欧洲近视治疗市场预测至 2030 年 - 区域分析 - 按类型、治疗、年龄层和最终用户Europe Myopia Treatment Market Forecast to 2030 - Regional Analysis - by Type, Treatment, Age Group, and End User |
2022年欧洲近视治疗市值为25.1879亿美元,预计2030年将达到47.4613亿美元;预计2022年至2030年复合年增长率为8.2%。
近视治疗意识的提高推动了欧洲近视治疗市场
人们对近视治疗选择的认识不断提高,推动了近视治疗市场的大幅成长。最近的一项市场分析显示,人们对近视管理策略的认识不断提高,尤其是家长和眼科保健专业人士,导致近视控制措施的实施大幅增加。全球眼保健领域的领导者正在与该国三所最好的验光学校合作,从 2024 年开始为试点小组提供扩展近视治疗。近视得不到控制的后果,人们已经显着转向主动的近视管理方法。这一趋势进一步推动了角膜塑形术和药物干预等近视治疗技术的采用,导致市场规模显着增长,在过去两年增长了25%以上。提高人们对近视作为公共卫生问题的认识并促进近视管理解决方案的可行性的集体努力正在推动市场成长并培育积极主动的视力保健文化。这种势头可能会继续推动近视治疗的进步,强调意识在塑造近视管理和治疗策略方面的关键作用。
欧洲近视治疗市场概况
欧洲近视治疗市场包括德国、法国、英国、西班牙、义大利和欧洲其他地区的综合市场。欧洲在全球近视治疗市场中占据重要地位,预计在预测期内将出现强劲的成长。由于老年人口的增加、欧洲对预防保健的日益重视以及该地区推出的产品数量的增加,预计该地区的市场将成长。德国老年人口的广泛增加为该国更多地采用眼保健补充剂提供了有利可图的机会。 《2017年世界人口老化》显示,2017年德国60岁以上人口约占总人口的28%,预计到2050年将上升至近37.6%。男性为78 岁。如此高的预期寿命可能会影响眼睛健康,最终在预测期内推动德国近视治疗市场的发展。
欧洲近视治疗市场收入及 2030 年预测(百万美元)
欧洲近视治疗市场细分
欧洲近视治疗市场按类型、治疗、年龄层、最终用户和国家分类。
根据类型,欧洲近视治疗市场分为高度近视、退化性近视和进行性近视。到 2022 年,高度近视细分市场将占据欧洲近视治疗市场最大份额。
在治疗方面,欧洲近视治疗市场细分为低剂量阿托品眼药水、隐形眼镜、角膜塑形镜和屈光手术。到2022年,低剂量阿托品眼药水区隔市场将占据欧洲近视治疗市场最大份额。
依年龄组别划分,欧洲近视治疗市场分为成人近视和儿童近视。到 2022 年,成人近视细分市场将占据更大的欧洲近视治疗市场。
根据最终用户,欧洲近视治疗市场分为医院和诊所、专科诊所和屈光手术中心。 2022 年,医院和诊所细分市场占据欧洲近视治疗市场最大份额。
依国家划分,欧洲近视治疗市场分为德国、英国、义大利、法国、西班牙和欧洲其他地区。 2022年,德国在欧洲近视治疗市场份额中占据主导地位。
Alcon AG、Bausch Health Companies Inc、Carl Zeiss AG、CooperVision Inc、Eyes Vision SL、Haag-Streit AG、Johnson & Johnson Vision Care Inc、Nidek Co Ltd 和 Ziemer Ophthalmic Systems AG 是欧洲近视领域的领先公司之一治疗市场。
The Europe myopia treatment market was valued at US$ 2,518.79 million in 2022 and is expected to reach US$ 4,746.13 million by 2030; it is estimated to register a CAGR of 8.2% from 2022 to 2030.
Increased Awareness of Myopia Treatment drives Europe Myopia Treatment Market
The heightened awareness of myopia treatment options drives the substantial growth of the myopia treatment market. A recent market analysis revealed that the increasing awareness of myopia management strategies, particularly among parents and eyecare professionals, has led to a significant upsurge in implementing myopia control measures. The leader in global eye care is teaming up with three of the best optometry schools in the country to provide extended myopia therapy to a pilot group starting in 2024. As awareness campaigns, educational initiatives, and extensive research studies continue to shed light on the potential consequences of unmanaged myopia, there has been a notable shift toward proactive myopia management approaches. This trend has furthered the adoption of myopia treatment technologies, such as orthokeratology and pharmaceutical interventions, resulting in a remarkable increase in the market size, which has grown by over 25% in the last two years. The collective efforts to raise awareness about myopia as a public health concern and to promote the viability of myopia management solutions are propelling market growth and fostering a culture of proactive vision care. This momentum is likely to continue driving advancements in myopia treatment, emphasizing the pivotal role of awareness in shaping the landscape of myopia management and treatment strategies.
Europe Myopia Treatment Market Overview
The Europe myopia treatment market includes the consolidated markets for Germany, France, the UK, Spain, Italy, and the Rest of Europe. Europe occupies a significant position in the global myopia treatment market and is estimated to register a robust growth rate during the forecast period. The market growth in the region is expected due to the increasing geriatric population, rising emphasis on preventive care in Europe, and rising number of product introductions in the region. Germany's extensively increasing geriatric population represents a lucrative opportunity for increased adoption of eye health supplements in the country. As per the "World Population Ageing 2017," in 2017, ~28% of the total population of Germany was aged 60 or more, and it is estimated to rise to nearly 37.6% by the year 2050. It also mentioned that life expectancy is projected to be 83 years for women and 78 years for men. Such higher life expectancy will likely impact eye health, eventually driving the Germany myopia treatment market during the forecast period.
Europe Myopia Treatment Market Revenue and Forecast to 2030 (US$ Million)
Europe Myopia Treatment Market Segmentation
The Europe myopia treatment market is categorized into type, treatment, age group, end user, and country.
Based on type, the Europe myopia treatment market is segmented into high myopia, degenerative myopia, and progressive myopia. The high myopia segment held the largest Europe myopia treatment market share in 2022.
In terms of treatment, the Europe myopia treatment market is segmented into low-dose atropine eye drops, contact lenses, ortho-k, and refractive surgery. The low-dose atropine eye drops segment held the largest Europe myopia treatment market share in 2022. Furthermore, the refractive surgery segment is subcategorized into LASIK and PRK.
By age group, the Europe myopia treatment market is bifurcated into adult myopia and childhood myopia. The adult myopia segment held a larger Europe myopia treatment market share in 2022.
Based on end user, the Europe myopia treatment market is categorized into hospitals and clinics, specialty clinics, and refractive surgery centers. The hospitals and clinics segment held the largest Europe myopia treatment market share in 2022.
Based on country, the Europe myopia treatment market is categorized into Germany, the UK, Italy, France, Spain, and the Rest of Europe. Germany dominated the Europe myopia treatment market share in 2022.
Alcon AG, Bausch Health Companies Inc, Carl Zeiss AG, CooperVision Inc, Eyes Vision SL, Haag-Streit AG, Johnson & Johnson Vision Care Inc, Nidek Co Ltd, and Ziemer Ophthalmic Systems AG are among the leading companies operating in the Europe myopia treatment market.